Carmignac Portfolio Emergents: Letter from the Fund Managers - Q3 2025

Published on
October 24, 2025
Read time
5 minute(s) read
+11.3%
Performance of the third quarter for Carmignac P. Emergents F EUR Acc versus +10.53% for its reference indicator1.
+38.9%
Performance of Carmignac P. Emergents F EUR Acc over 3 years versus +37.7% for its reference indicator.
1st quartile
Carmignac P. Emergents ranking within its category Morninstar2 for its performance since the beginning of the year and 1 year.

During the third quarter, Carmignac Portfolio Emergents F EUR Acc delivered a solid gain of +11.35%, outperforming its reference indicator, which rose by +10.53%. Since the beginning of the year, the Fund has advanced by +17.45%, compared with +12.39% for its benchmark, representing an outperformance of +5.1%.
As is typical of the strategy, performance was primarily driven by stock selection, with balanced contributions across both countries and sectors.

Market environment

The first nine months of 2025 have marked the strongest three-quarter performance for emerging markets in fifteen years, with the index posting gains in every consecutive month so far this year. The MSCI EM Index closed the third quarter within 8% of its early-2021 market high. The pace of gains accelerated through September, supported by the US Federal Reserve’s long-awaited rate-cutting cycle. At the same time, the surge of investment linked to artificial intelligence continued to drive enthusiasm across Asia. North Asian technology markets — particularly South Korea, Taiwan, and parts of China — have led the gains, with Korea and Taiwan continuing to reach new all-time highs.

This strength in emerging markets coincided with a markedly weaker US dollar, as well as a temporary détente in US–China trade tensions during the period. Elsewhere, tariff headlines continued to abound, with many Asian countries securing agreements that were seen as manageable, and the resulting certainty was met with relief. India and Brazil, however, were each hit with 50% headline tariff rates on grounds that were more politically than economically motivated, making it clear that the White House is using tariffs as a tool to advance foreign policy goals and promote the US diplomatic agenda in ways that previously seemed unthinkable. These moves are largely symbolic — an opening gambit in negotiations — and therefore we do not see them as altering the attractiveness of these countries as investment destinations.

In China, most top-down indicators remained soft, yet industrial profit growth firmed up, ostensibly reflecting the early fruits of the government’s “anti-involution” policy aimed at curbing overcapacity. We remain unconvinced that this will drive meaningful change without a concurrent demand-side boost, which is not expected. Regardless, history shows that the Chinese equity market and the real economy are often uncorrelated. Chinese offshore H-shares have seen the traditional discount to their onshore A-share counterparts narrow from 43% at the beginning of the year to a six-year low of 17%, signaling a return of both retail and foreign investor appetite. Support can be attributed to optimism surrounding the anti-involution reforms, technology localization potential, and incremental government measures to support the equity market.

India lagged during the quarter due to slower growth, tariff threats, and an unclear path for its AI strategy. However, the government has accelerated the pace of reforms, notably by adjusting the GST (Goods and Services Tax), which could spur higher consumption. Valuations, while still high, have come down after underperforming broader EM by close to 20% during the quarter. We are now starting to see signs of stabilization within a context of still-positive long-term potential.

The Latin American markets have once again been dominated by politics. Much of the early-year rally in Brazil was driven by mean reversion, along with expectations that Lula would not run in the next election. Trump’s support for Bolsonaro has re-polarized the political landscape, though the US leader has now agreed to meet Lula. Ongoing performance in Brazil will likely be heavily influenced by electoral noise and the trajectory of the Selic rate.

Argentina experienced significant turmoil as the government depleted FX reserves to defend the peso and contain inflation ahead of October’s critical midterm elections, pushing the country to the brink of economic collapse and leaving it reliant on potential US financial support. Given this backdrop, we maintain no exposure to the country.

In the CEEMEA region (Central and Eastern Europe, the Middle East and Africa), Saudi Arabia made gains following the announcement of forthcoming changes to foreign ownership limits, while South Africa benefited from the strong rally in gold.

Performance review

In this context, Carmignac Portfolio Emergents delivered a solid performance of +11.35%. As is typical for the Fund, performance over the quarter was predominantly driven by strong stock selection. Pleasingly, this performance was diversified across both countries and sectors, with our top ten contributors spanning five countries and five sectors. The detractors this quarter, however, were more concentrated in one area, with five of the bottom ten contributors coming from India. It should be noted that while absolute performance in India has been weak, our stock selection in that market has been significantly positive and reflects our discipline and ability to identify and value assets on a risk-adjusted basis.

Taiwan was by far the largest positive contributor on a country basis, owing to positions in mid-cap AI hardware supply chain names Elite Material and Lite-On, which underline our strategic approach to AI investment opportunities — looking beyond the large caps in the limelight in pursuit of the most compelling investments. Diversifying our exposure through lesser-known stock picks has not only helped us deliver enhanced returns, but also spread risk across different companies and various parts of the technology value chain.

China and Brazil also contributed positively, with our large positions in Chinese online discount retailer Vipshop and Brazil’s utilities company Eletrobras experiencing strong rallies and closing some of the significant valuation anomalies that had previously attracted us to these names. Meanwhile, Mexico and Indonesia detracted during the quarter.

On a sector basis, Industrials was a key highlight, with our positions in Didi (China’s leading ride-hailing company) and CATL (Chinese battery manufacturer) being the main contributors. Our selective positioning in Consumer Discretionary detracted, as we continue to avoid index heavyweights such as Alibaba, which surged on renewed AI optimism. Despite the share price rebound, we believe earnings headwinds persist and that valuations do not yet justify exposure.

Portfolio changes

Portfolio activity was limited, with one new purchase and one sale during the quarter.

We reinitiated a position in the Chinese battery leader CATL. We had originally purchased CATL in May during its Hong Kong IPO, but quickly sold it after the stock performed very strongly in the initial days following the listing, resulting in an atypical premium to its A-share listing. In July, we observed that the premium had risen to 23%, prompting us to repurchase CATL — this time via the A-share. CATL stands out as a global leader and is particularly well positioned within the energy transition theme thanks to its energy storage business — an area essential for the advancement of renewable energy. The rapid adoption of autonomous driving technologies also represents a significant tailwind for CATL, as self-driving vehicles will require substantially more onboard energy.

We exited our remaining position in Galicia, an Argentine bank, at the beginning of the quarter due to concerns about the country’s economic and political environment, where we felt the risks were too high.

More broadly, the portfolio became slightly more concentrated during the quarter, ending the period with 37 holdings, within the 35–45 target range. Our key actions involved ongoing trimming of strong performers to take profits and redeploying the proceeds into undervalued or lagging names with solid upside potential.

Outlook

Looking ahead, with the MSCI EM Index now trading at around 14 times forward earnings, we are becoming more mindful of the potential for a short-term pause in performance. However, this comes in a context where gross margins, Return on Equity (ROE) and Return on Invested Capital (ROIC) levels have also improved. As for China, we note that Chinese equities have only recovered a fraction of their three-year underperformance.

We expect increasing volatility in the coming months, and it is likely that near-term market performance will, to a large extent, be dictated by the outcome of the Trump–Xi meeting at the end of October. Nevertheless, we continue to believe that the longer-term EM rally still has multiple supports, including USD weakness, rate cuts, improvements in corporate governance and industrial policy across the region, greater certainty on trade dynamics, AI supply-chain beneficiaries, and continued earnings growth — all alongside broader global diversification of positioning. These new dynamics highlight that Emerging Market equities are no longer simply a high-beta proxy for developed market growth. Instead, they are increasingly viewed as an alternative to slowing developed markets.

While we are somewhat more cautious towards the frothier areas of the market, we remain confident that we continue to hold companies with structural advantages in areas such as technology, the energy transition, and mobility. We observe a new, more growth-oriented environment, but remain firmly committed to maintaining a strong balance across the portfolio and valuation discipline — always anchored in fundamentals rather than market sentiment.

Positioning as of 30/09/2025

1Reference indicator: MSCI EM NR (USD) (Reinvested net dividends rebalanced quarterly), Carmignac 30/09/2025. Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor).
2Morningstar category: Global Emerging Markets Equity.

Carmignac Portfolio Emergents

Grasping the most promising opportunities within the emerging universe

Carmignac Portfolio Emergents F EUR Acc

ISIN: LU0992626480
Recommended minimum investment horizon
5 years
Risk indicator*
4/7
SFDR - Fund Classification**
Article 9

*Risk Scale from the KID (Key Information Document). Risk 1 does not mean a risk-free investment. This indicator may change over time. **Sustainable Finance Disclosure Regulation (SFDR) 2019/2088. The SFDR classification of the Funds may change over time.

Main risks of the fund

Equity: The Fund may be affected by stock price variations, the scale of which is dependent on external factors, stock trading volumes or market capitalization.
Emerging Markets: Operating conditions and supervision in "emerging" markets may deviate from the standards prevailing on the large international exchanges and have an impact on prices of listed instruments in which the Fund may invest.
Currency: Currency risk is linked to exposure to a currency other than the Fund’s valuation currency, either through direct investment or the use of forward financial instruments.
Discretionary Management: Anticipations of financial market changes made by the Management Company have a direct effect on the Fund's performance, which depends on the stocks selected.
The Fund presents a risk of loss of capital. Please refer to the Fund’s prospectus to view the exhaustive list of risks.

Fees

ISIN: LU0992626480
Entry costs
We do not charge an entry fee. 
Exit costs
We do not charge an exit fee for this product.
Management fees and other administrative or operating costs
1.15% of the value of your investment per year. This estimate is based on actual costs over the past year.
Performance fees
20.00% when the share class overperforms the Reference indicator during the performance period. It will be payable also in case the share class has overperformed the reference indicator but had a negative performance. Underperformance is clawed back for 5 years. The actual amount will vary depending on how well your investment performs. The aggregated cost estimation above includes the average over the last 5 years, or since the product creation if it is less than 5 years.
Transaction Cost
0.39% of the value of your investment per year. This is an estimate of the costs incurred when we buy and sell the investments underlying the product. The actual amount varies depending on the quantity we buy and sell.

Performance

ISIN: LU0992626480
Carmignac Portfolio Emergents+17.4+5.5+9.8−14.3−10.3+44.9+25.5−18.2+19.8+1.7
Reference Indicator+12.4+14.7+6.1−14.9+4.9+8.5+20.6−10.3+20.6+14.5
Carmignac Portfolio Emergents+11.6%+5.3%+7.1%
Reference Indicator+11.2%+7.0%+7.4%

Source: Carmignac at Sep 30, 2025.
Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). The Fund presents a risk of loss of capital.
The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged.

Reference Indicator: MSCI EM NR index

FOR PROFESSIONAL CLIENTS ONLY
This document is issued by, or communicated on behalf of, Carmignac Middle East Ltd, a company incorporated under the laws of the Dubai International Financial Centre with company number CL 13413 registered at GD-PB-04-01-OF-01-0, Level 1, DIFC Fund Centre, Level POD, Gate District Precinct Building 04, Dubai International Financial Centre, Dubai, United Arab Emirates and regulated by the Dubai Financial Services Authority under reference number F013638.
This document is intended solely for Professional Clients and Market Counterparties, as defined under the applicable rules of the Dubai Financial Services Authority (“DFSA”). It must not be relied upon by, or distributed to, Retail Clients or any other person.
The fund(s) referred to in this document are foreign fund(s) domiciled and regulated in Luxembourg by the Commission de Surveillance du Secteur Financier (“CSSF”). Carmignac Portfolio refers to the sub-funds of Carmignac Portfolio SICAV, an investment company under Luxembourg law, conforming to the UCITS Directive. Carmignac Private Evergreen refers to the Private Evergreen sub-fund of the SICAV Carmignac S.A. SICAV – PART II UCI, registered with the Luxembourg RCS under number B285278. Unless expressly stated otherwise, they are not domiciled in, authorised by, or subject to regulation or approval by the DFSA. The DFSA has not approved, reviewed or verified this document, the prospectus or any other fund documentation, and the authority does not accept responsibility for the information contained in them or for the merits of an investment in the fund(s).
This document is provided for information purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any financial instrument or fund interest. Any investment decision should be made solely on the basis of the applicable legal offering documents, including the prospectus and, where applicable, the key information document, and after obtaining independent professional advice as appropriate. The information contained in this material may be partial information and may be modified without prior notice. They are expressed as of the date of writing and are derived from proprietary and non-proprietary sources deemed by Carmignac to be reliable, are not necessarily all-inclusive and are not guaranteed as to accuracy. As such, no warranty of accuracy or reliability is given and no responsibility arising in any other way for errors and omissions (including responsibility to any person by reason of negligence) is accepted by Carmignac, its officers, employees or agents.
Access to the Funds may be subject to restrictions regarding certain persons or countries. This material is not directed to any person in any jurisdiction where (by reason of that person’s nationality, residence or otherwise) the material or availability of this material is prohibited. Persons in respect of whom such prohibitions apply must not access this material. Taxation depends on the situation of the individual. The Funds are not registered for retail distribution in Asia, in Japan, in North America, nor are they registered in South America. Carmignac Funds are registered in Singapore as restricted foreign scheme (for professional clients only). The Funds have not been registered under the US Securities Act of 1933. The Funds may not be offered or sold, directly or indirectly, for the benefit or on behalf of a «U.S. person», according to the definition of the US Regulation S and FATCA. The risks, fees and ongoing charges are described in the KID (Key Information Document). The KID must be made available to the subscriber prior to subscription. Prospective investors should read the fund's prospectus/KID and consult their own advisers before making any investment decision. Investors may lose some or all their capital, as the capital in the funds is not guaranteed.
Investment in the fund(s) involves risk, including possible loss of capital. The value of investments and income may go down as well as up, and investors may not recover the amount originally invested. Past performance is not a reliable indicator of future results. Performances are net of fees (excluding possible entrance fees charged by the distributor). The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged. Any target, forecast, projection or forward-looking statement is based on assumptions and is not a guarantee of future performance or return.
Reference to certain securities and financial instruments is for illustrative purposes to highlight stocks that are or have been included in the portfolios of funds in the Carmignac range. This is not intended to promote direct investment in those instruments, nor does it constitute investment advice. The Management Company is not subject to prohibition on trading in these instruments prior to issuing any communication. The portfolios of Carmignac funds may change without previous notice.
The reference to a ranking or prize, is no guarantee of the future results of the UCITS or the manager.
Morningstar Rating™: © Morningstar, Inc. All Rights Reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
Funds classified as Article [8/9] products under the EU Sustainable Finance Disclosure Regulation (“SFDR”) are subject to an EU classification only, and does not represent a label, approval or endorsement by the Dubai Financial Services Authority or any UAE authority. Funds that pursue ESG related objectives alongside financial objectives do so without any guarantee that such ESG objectives will be achieved. ESG data and indicators may be based on third party sources, estimates and evolving methodologies and should not be viewed as a precise or comprehensive measure of sustainability performance.
The fund(s) may be subject to investment, market, liquidity, currency, credit, counterparty, concentration and other risks as described in the applicable offering documents. Prospective investors should conduct their own due diligence and carefully consider the risks, investment objectives, costs and suitability of an investment before making any decision.
The Management Company can cease promotion in your country anytime. Investors have access to a summary of their rights at section 5 entitled "summary of investor rights" at the following link: https://www.carmignac.com/en-ae/regulatory-information